TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02764736

Atorvastatin Reduces Chronic Inflammation and aVerage Epogen Dose (ARChIVED)

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“Enrollment did not progress as anticipated. No participants enrolled.”

The sponsor’s own words in the registry.

Life of this trial

201620172018Planned start2016-03-04 (planned)Registered2016-03-18Withdrawn (as of)2017-05-18

Vital statistics

Status
Withdrawn
Phase
Na
Sponsor
Albert Einstein Healthcare Network
Sponsor type
University, hospital or other
Conditions
Complication of Renal Dialysis
Interventions
Atorvastatin
Participants
0

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.